Research ArticleClinical Studies
Prognostic Role of Pre-Treatment Symptoms for Survival of Patients Irradiated for Brain Metastases
DIRK RADES, HEINKE C. HANSEN, LIESA DZIGGEL, STEFAN JANSSEN and STEVEN E. SCHILD
Anticancer Research August 2019, 39 (8) 4273-4277; DOI: https://doi.org/10.21873/anticanres.13591
DIRK RADES
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
HEINKE C. HANSEN
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
LIESA DZIGGEL
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
STEFAN JANSSEN
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
2Medical Practice for Radiotherapy and Radiation Oncology, Hannover, Germany
STEVEN E. SCHILD
3Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S.A.
In this issue
Prognostic Role of Pre-Treatment Symptoms for Survival of Patients Irradiated for Brain Metastases
DIRK RADES, HEINKE C. HANSEN, LIESA DZIGGEL, STEFAN JANSSEN, STEVEN E. SCHILD
Anticancer Research Aug 2019, 39 (8) 4273-4277; DOI: 10.21873/anticanres.13591
Jump to section
Related Articles
- No related articles found.
Cited By...
- Neurological Death After Radiotherapy for Brain Metastases: Role of the LabBM Score
- Pre-Treatment Seizures in Patients With 1-3 Cerebral Metastases Receiving Local Therapies Plus Whole-brain Radiotherapy
- Seizures Prior to Whole-brain Irradiation for Metastatic Disease: Prevalence, Risk Factors and Association With Survival
- The Results of Whole-brain Radiotherapy for Elderly Patients With Brain Metastases from Urinary Bladder Cancer